Methods for Treating Disorders of Tissue Function by Restoration of Morphogenetic Field Connectivity: General Prior Art Disclosure
March 2026
in “
Zenodo (CERN European Organization for Nuclear Research)
”
Studysummary This document outlines a defensive publication on restoring gap-junction-mediated morphogenetic field connectivity to address disorders of tissue function, with no new clinical results reported.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
This document is a defensive publication that establishes prior art for methods aimed at treating disorders of tissue function by restoring gap-junction-mediated morphogenetic field connectivity. It identifies the primary issue in various tissue dysfunctions as the disconnection of cell populations from intercellular bioelectric communication, which is not influenced by membrane voltage state and is not addressed by current treatments. This disclosure serves as the foundational prior art for related filings specifically targeting androgenic alopecia and age-related sexual dysfunction.
